Papers: 24 Sep 2012 - 1 Oct 2012

Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation.

Papers:

Editors' Pick

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.

Ottoboni L, Keenan BT, Tamayo P, Kuchroo M, Mesirov JP, Buckle GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL

Sci Transl Med. 2012 Sep 26; 4(153):153ra131. PMID: 23019656. Abstract

Editors' Pick

Subcortical atrophy and cognition: Sex effects in multiple sclerosis.

Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJG, Barkhof F

Neurology. 2012 Sep 26. PMID: 23019265. Abstract

Editors' Pick

Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica.

Ren Z, Wang Y, Duan T, Patel J, Liggett T, Loda E, Brahma S, Goswami R, Grouse C, Byrne R, et al.

J Immunol. 2012 Sep 24. PMID: 23008451. Abstract

Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.

Yao Y, Han W, Liang J, Ji J, Wang J, Cantor H, Lu L

Eur J Immunol. 2013 Jan; 43(1):125-36. Epub 2012 Nov 07. PMID: 23002042. Abstract

Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.

Langwińska-Wośko E, Szulborski K, Broniek-Kowalik K

Med Sci Monit. 2012 Oct; 18(10):CS82-84. PMID: 23018359. Abstract

Assessment of statistical significance and clinical relevance.

Kieser M, Friede T, Gondan M

Stat Med. 2012 Sep 28. PMID: 23018516. Abstract

Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.

Kuroda H, Fujihara K, Takano R, Takai Y, Takahashi T, Misu T, Nakashima I, Sato S, Itoyama Y, Aoki M

J Neuroimmunol. 2012 Sep 24. PMID: 23017732. Abstract

Correlation of cognitive impairment and thalamic atrophy in MS: For men only?

Fisher E, Benedict RHB

Neurology. 2012 Sep 26. PMID: 23019258. Abstract

Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?

Disanto G, Ramagopalan SV

Mult Scler. 2012 Oct; 18(10):1370-1. PMID: 23014625. Abstract

Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.

Söllner J, Mayer P, Heinzel A, Fechete R, Siehs C, Oberbauer R, Mayer B

Mol Biosyst. 2012 Sep 27. PMID: 23014771. Abstract

Management of optic neuritis as a clinically first event of multiple sclerosis.

Kale N

Curr Opin Ophthalmol. 2012 Nov; 23(6):472-6. PMID: 23014264. Abstract

β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.

Xu J, Wagoner G, Douglas JC, Drew PD

J Neuroimmunol. 2012 Sep 22. PMID: 23010281. Abstract

Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Li H, Gonnella P, Safavi F, Vessal G, Nourbakhsh B, Zhou F, Zhang G-X, Rostami A

J Neuroimmunol. 2012 Sep 22. PMID: 23010280. Abstract

Evaluation of olfactory dysfunction in neurodegenerative diseases.

Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, Marino S

J Neurol Sci. 2012 Sep 22. PMID: 23010543. Abstract

Scoring treatment response in patients with relapsing multiple sclerosis.

Sormani M, Rio J, Tintorè M, Signori A, Li D, Cornelisse P, Stubinski B, Stromillo M, Montalban X, De Stefano N

Mult Scler. 2012 Sep 25. PMID: 23012253. Abstract

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.

Wickström A, Nyström J, Svenningsson A

Mult Scler. 2012 Sep 25. PMID: 23012254. Abstract

Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.

Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X

Mult Scler. 2012 Sep 25. PMID: 23012252. Abstract

[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]

Davydovskaia MV, Boĭko AN, Podoprigora AE, Pronin IN, Kornienko VN, Gusev EI

Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112(7):36-41. PMID: 23011427. Abstract

Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.

Dogonowski A-M, Siebner HR, Sørensen P S, Wu X, Biswal B, Paulson OB, Dyrby TB, Skimminge A, Blinkenberg M, Madsen KH

Mult Scler. 2012 Sep 25. PMID: 23012251. Abstract

[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].

Oreja-Guevara C

Rev Neurol. 2012 Oct 1; 55(7):421-30. PMID: 23011861. Abstract

Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'

Shechter R, Schwartz M

J Pathol. 2012 Sep 24. PMID: 23007711. Abstract

Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.

Verma R, Praharaj H N, Patil TB, Giri P

BMJ Case Rep. 2012; 2012. PMID: 23008381. Abstract

Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.

Prosperini L, Giannì C, Barletta V, Mancinelli C, Fubelli F, Borriello G, Pozzilli C

J Neurol Sci. 2012 Sep 21. PMID: 23006974. Abstract

Self-efficacy and health status improve after a wellness program in persons with multiple sclerosis.

Ng A, Kennedy P, Hutchinson B, Ingram A, Vondrell S, Goodman T, Miller D

Disabil Rehabil. 2012 Sep 25. PMID: 23004028. Abstract

Disease mechanisms in MS: A role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions.

Malpass K

Nat Rev Neurol. 2012 Sep 25. Epub 2012 Sep 25. PMID: 23007700. Abstract

Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.

Errede M, Girolamo F, Ferrara G, Strippoli M, Morando S, Boldrin V, Rizzi M, Uccelli A, Perris R, Bendotti C, et al.

J Neuropathol Exp Neurol. 2012 Oct; 71(10):840-854. PMID: 23001217. Abstract

Progressive multiple sclerosis: pathology and pathogenesis.

Lassmann H, van Horssen J, Mahad D

Nat Rev Neurol. 2012 Sep 25. Epub 2012 Sep 25. PMID: 23007702. Abstract

[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].

Bioorg Khim. 2012 May-Jun; 38(3):306-14. PMID: 22997702. Abstract

Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.

Liu Y, Duan Y, Liang P, Jia X, Yu C, Ye J, Butzkueven H, Dong H, Li K

Acta Radiol. 2012 Sep 21. PMID: 23002142. Abstract

Hernández-Lahoz C, Rodrigo L

Med Clin (Barc). 2012 Sep 18. PMID: 22998972. Abstract

Fine-Tuning S1P Therapeutics.

Obinata H, Hla T

Chem Biol. 2012 Sep 21; 19(9):1080-2. PMID: 22999874. Abstract

Time limited immunomodulatory functions of transplanted neural precursor cells.

Fainstein N, Einstein O, Cohen ME, Brill L, Lavon I, Ben-Hur T

Glia. 2012 Sep 21. PMID: 23001547. Abstract

Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study.

Dhib-Jalbut S, Sumandeep S, Valenzuela R, Ito K, Patel P, Rametta M

J Neuroimmunol. 2012 Sep 18. PMID: 22999187. Abstract

Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.

Zivadinov R, Weinstock-Guttman B

J Vasc Interv Radiol. 2012 Oct; 23(10):1308-10. PMID: 22999749. Abstract

A Potent and Selective S1P(1) Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis.

Quancard J, Bollbuck B, Janser P, Angst D, Berst F, Buehlmayer P, Streiff M, Beerli C, Brinkmann V, Guerini D, et al.

Chem Biol. 2012 Sep 21; 19(9):1142-51. PMID: 22999882. Abstract

Dual role of Response gene to complement-32 in multiple sclerosis.

Tegla CA, Cudrici CD, Azimzadeh P, Singh AK, Trippe R, Khan A, Chen H, Andrian-Albescu M, Royal W, Bever C, et al.

Exp Mol Pathol. 2012 Sep 19. PMID: 23000427. Abstract

Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.

Nakano H, Tanaka M, Kinoshita M, Tahara M, Matsui M, Tanaka K, Konishi T

Epilepsy Res. 2012 Sep 20. PMID: 23000513. Abstract

Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.

Oh K, Park H-B, Seo M W, Byoun O-J, Lee D-S

Clin Immunol. 2012 Aug 23; 145(2):122-132. PMID: 23001131. Abstract

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.

Dominguez-Mozo M I, Garcia-Montojo M, de Las Heras V, Garcia-Martinez A, Arias-Leal A M, Casanova I, Arroyo R, Alvarez-Lafuente R

BMC Neurol. 2012 Sep 25; 12(1):107. Epub 2012 Sep 25. PMID: 23009575. Abstract

Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Sajedi S A, Abdollahi F

BMC Neurol. 2012 Sep 24; 12(1):100. Epub 2012 Sep 24. PMID: 22998435. Abstract

The interplay between the intestinal microbiota and the brain.

Collins SM, Surette M, Bercik P

Nat Rev Microbiol. 2012 Sep 24. Epub 2012 Sep 24. PMID: 23000955. Abstract

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.

Grau-Lopez L, Granada M L, Raich D, Naranjo M, Borras FE, Martinez-Caceres EM, Ramo-Tello C

BMC Neurol. 2012 Sep 24; 12(1):103. Epub 2012 Sep 24. PMID: 23006125. Abstract

Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Morrow SA, Smerbeck A, Patrick K, Cookfair D, Weinstock-Guttman B, Benedict RHB

J Neurol. 2012 Sep 23. Epub 2012 Sep 23. PMID: 23001556. Abstract

Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.

Karara AM, Macky TA, Sharawy MH

Ophthalmic Res. 2012 Sep 19; 49(1):25-29. Epub 2012 Sep 19. PMID: 23007229. Abstract

The impact of osteopontin gene variations on multiple sclerosis development and progression.

Comi C, Cappellano G, Chiocchetti A, Orilieri E, Buttini S, Ghezzi L, Galimberti D, Guerini F, Barizzone N, Perla F, et al.

Clin Dev Immunol. 2012; 2012:212893. Epub 2012 Sep 11. PMID: 23008732. Abstract

Targeting IRF4 in autoimmune diseases.

Xu W-D, Pan H-F, Ye D-Q, Xu Y

Autoimmun Rev. 2012 Oct; 11(12):918-24. Epub 2012 Aug 21. PMID: 23010632. Abstract

The therapeutic potential of cannabis and cannabinoids.

Grotenhermen F, Müller-Vahl K

Dtsch Arztebl Int. 2012 Jul; 109(29-30):495-501. Epub 2012 Jul 23. PMID: 23008748. Abstract

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Papers: 24 Sep 2012 - 1 Oct 2012

MSDF Footer

Search form

Papers: 24 Sep 2012 - 1 Oct 2012